Clifford Chance Guides Cinven's $589M Pharma Co. Buy

Law360, New York (October 15, 2012, 1:57 PM EDT) -- Private equity-backed Cinven Partners LLP has acquired international drug manufacturer Amdipharm Group from its private owners for about £367 million ($589.5 million), in its second major move this year in the pharmaceutical business, Cinven announced Monday.

Per an agreement, the acquisition will be financed by a mix of deb and cash, Rebecca Flower, a spokeswoman for Cinven, told Law360. The deal will leave Amdipharm's founders with a significant, but unspecified stake, according to Cinven.

While the company will continue to operate as a stand-alone business immediately...
To view the full article, register now.